Julie Cooke - Oct 2, 2020 Form 4/A - Amendment Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Role
Chief Human Resources Officer
Signature
/s/ Darin Lippoldt, Attorney-in-Fact
Stock symbol
NBIX
Transactions as of
Oct 2, 2020
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/3/2023, 05:20 PM
Date Of Original Report
Oct 6, 2020
Next filing
Oct 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NBIX Common Stock 9.55K Oct 2, 2020 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The initial Form 4 filed on 10/06/2020 inadvertently omitted 5 shares that the reporting person owned directly associated with the purchase of such shares on August 31, 2020 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan